What should be the primary target of "treat to target" in psoriatic arthritis?

What should be the primary target of "treat to target" in psoriatic arthritis?

<h4>Background</h4> <p>Treat to Target in psoriatic arthritis (PsA) recommendations have stated that the target should be remission or inactive disease. Potential definitions include Very Low Disease Activity (VLDA), PsA Disease Activity Score (PASDAS) near remission, Disease Act...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Coates, LC, Lubrano, E, Perrotta, FM, Emery, P, Conaghan, PG, Helliwell, PS
Format: Journal article
Sprache:English
Veröffentlicht: Journal of Rheumatology 2018

Ähnliche Einträge

Ähnliche Einträge